Suppr超能文献

非酒精性脂肪性肝病与结直肠腺瘤之间的关联:一项系统评价和荟萃分析。

Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.

作者信息

Ding Wenjin, Fan Jiangao, Qin Jianjun

机构信息

Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China.

Shanghai Institute of Disaster Prevention and Relief, Tongji University Shanghai, China.

出版信息

Int J Clin Exp Med. 2015 Jan 15;8(1):322-33. eCollection 2015.

Abstract

BACKGROUND AND AIMS

Several existing studies indicated that nonalcoholic fatty liver disease (NAFLD) may be associated with colorectal adenoma, but the results and risk factors are controversial. A systematic review of studies was conducted to explore these issues by meta-analysis.

METHODS

We searched the Pubmed, Embase, Cochrane library, Medline and Web of Science databases for studies published before May 30(th), 2014. A statistical analysis was performed using RevMan 5.2 software.

RESULTS

Seven studies involving 11,905 participants from different regions were included. Among them, five trials carried out subgroup of NAFLD patients in colorectal adenoma population. The result showed NAFLD was significantly correlated with adenoma of colon (Odds ratio [OR] = 1.56, 95% confidence interval [CI]: 1.22-1.99, P = 0.0003). It could be found in stratified analysis that patients had more chance to get multiple adenomas when they suffered NAFLD (Rate ratio [RR]: 1.52, 95% CI: 1.08-2.13, P = 0.02). Such risk factors of NAFLD as age, waist circumference, body mass index (BMI), disorder of lipid metabolism, hyperglycemia and high blood pressure (HBP) increased risk of colorectal adenoma (Age: mean difference [MD]: 2.81, 95% CI: 0.33-5.28; Waist: MD: 2.84, 95% CI: 2.14-3.54; BMI: MD: 0.85, 95% CI: 0.69-1.01; High-density lipoprotein: MD: -2.46, 95% CI: -3.68 to -1.24; Triglyceride: MD: 16.12, 95% CI: 8.89-23.36; Low-density lipoprotein: MD: 6.04, 95% CI: 3.60-8.48; Cholesterol: MD: 4.25, 95% CI: 0.87-7.63; Fasting glucose: MD: 2.27, 95% CI: 1.24-3.30; HBP: OR = 1.51, 95% CI: 1.22-1.88), while diabetes had no significant association with it (OR = 1.43, 95% CI: 0.94-2.17, P = 0.09). Besides, NAFLD didn't affect the location, size and advanced type of colorectal adenoma (P > 0.05).

CONCLUSION

The present systematic review and meta-analysis demonstrated NAFLD was closely associated with great risk of colorectal adenoma and its number, but not with its location, size and advanced type. Waist, obesity, lipid profiles, glucose, hypertension played roles in the process of colorectal adenoma.

摘要

背景与目的

多项现有研究表明,非酒精性脂肪性肝病(NAFLD)可能与结直肠腺瘤有关,但结果和危险因素存在争议。通过荟萃分析对相关研究进行系统评价以探讨这些问题。

方法

检索Pubmed、Embase、Cochrane图书馆、Medline和Web of Science数据库中2014年5月30日前发表的研究。使用RevMan 5.2软件进行统计分析。

结果

纳入7项研究,共11905名来自不同地区的参与者。其中,5项试验在结直肠腺瘤人群中对NAFLD患者进行了亚组分析。结果显示,NAFLD与结肠腺瘤显著相关(优势比[OR]=1.56,95%置信区间[CI]:1.22 - 1.99,P = 0.0003)。分层分析发现,NAFLD患者发生多个腺瘤的机会更多(率比[RR]:1.52,95% CI:1.08 - 2.13,P = 0.02)。NAFLD的年龄、腰围、体重指数(BMI)、脂质代谢紊乱、高血糖和高血压(HBP)等危险因素增加了结直肠腺瘤的风险(年龄:平均差[MD]:2.81,95% CI:0.33 - 5.28;腰围:MD:2.84, 95% CI:2.14 - 3.54;BMI:MD:0.85,95% CI:0.69 - 1.01;高密度脂蛋白:MD:-2.46, 95% CI:-3.68至-1.24;甘油三酯:MD:16.12, 95% CI:8.89 - 23.36;低密度脂蛋白:MD:6.04, 95% CI:3.60 - 8.48;胆固醇:MD:4.25, 95% CI:0.87 - 7.63;空腹血糖:MD:2.27,95% CI:1.24 - 3.30;HBP:OR = 1.51, 95% CI:1.22 - 1.88),而糖尿病与之无显著关联(OR = 1.43, 95% CI:0.94 - 2.17, P = 0.09)。此外,NAFLD不影响结直肠腺瘤的位置、大小和进展类型(P>0.05)

结论

本系统评价和荟萃分析表明,NAFLD与结直肠腺瘤及其数量密切相关,但与位置、大小和进展类型无关。腰围、肥胖以及血脂、血糖、高血压在结直肠腺瘤的发生过程中起作用

相似文献

2
Association between nonalcoholic fatty liver disease and colorectal adenoma: a systemic review and meta-analysis.
J Gastrointest Oncol. 2014 Dec;5(6):440-6. doi: 10.3978/j.issn.2078-6891.2014.061.
3
10
High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
J Gastroenterol Hepatol. 2020 Dec;35(12):2051-2065. doi: 10.1111/jgh.15158. Epub 2020 Jul 7.

引用本文的文献

4
Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses.
Ther Adv Chronic Dis. 2022 May 19;13:20406223221083508. doi: 10.1177/20406223221083508. eCollection 2022.
5
The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease.
Biomedicines. 2021 Oct 5;9(10):1401. doi: 10.3390/biomedicines9101401.
6
Does Nonalcoholic Fatty Liver Disease Increase the Risk for Extrahepatic Malignancies?
Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):215-219. doi: 10.1002/cld.1029. eCollection 2021 Mar.
7
Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study.
BMC Endocr Disord. 2021 Mar 18;21(1):51. doi: 10.1186/s12902-021-00721-w.
8
Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
PLoS One. 2021 Jan 25;16(1):e0245921. doi: 10.1371/journal.pone.0245921. eCollection 2021.
10
Week 2020 Poster Presentations.
United European Gastroenterol J. 2020 Oct;8(8_suppl):144-887. doi: 10.1177/2050640620927345.

本文引用的文献

2
Multiple polyps and colorectal cancer.
Chirurgia (Bucur). 2014 May-Jun;109(3):342-6.
4
Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review.
J Gastrointestin Liver Dis. 2014 Jun;23(2):195-202. doi: 10.15403/jgld.2014.1121.232.dsw1.
5
Diabetes mellitus increases risk for colorectal adenomas in younger patients.
World J Gastroenterol. 2014 Jun 14;20(22):6946-52. doi: 10.3748/wjg.v20.i22.6946.
6
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.
World J Gastroenterol. 2014 Jun 14;20(22):6821-5. doi: 10.3748/wjg.v20.i22.6821.
7
Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma.
Aliment Pharmacol Ther. 2014 Aug;40(4):325-37. doi: 10.1111/apt.12841. Epub 2014 Jun 18.
8
Clinical association between non-alcoholic fatty liver disease and the development of hypertension.
J Gastroenterol Hepatol. 2014 Nov;29(11):1926-31. doi: 10.1111/jgh.12643.
9
Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
Histopathology. 2014 Jun;64(7):951-62. doi: 10.1111/his.12343. Epub 2014 Feb 5.
10
Gender and racial differences in nonalcoholic fatty liver disease.
World J Hepatol. 2014 May 27;6(5):274-83. doi: 10.4254/wjh.v6.i5.274.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验